Matthew Brams

Serdexmethylphenidate/Dexmethylphenidate for Children With Attention-Deficit Hyperactivity Disorder: Reduction in Disorder Severity From a Laboratory Classroom Study

Abstract: Aim: To evaluate changes in attention-deficit hyperactivity disorder (ADHD) severity in children (aged 6-12 years) posttreatment with serdexmethylphenidate/dexmethylphenidate (S...

Matthew Brams ;

Mary Wiggin ;

01/19/2023

A Scintigraphy and Pharmacokinetic Study to Evaluate the Absorption and Distribution of Buspirone Hydrochloride from a Triple-Pulse, Timed-Release Tablet.

Abstract: Purpose: To obtain data for development of a precision-timed release buspirone hydrochloride tablet (CTx-2103) that will provide a once-daily, anxiety treatment. This study eluc...

Matthew Brams ;

Laurie Myers ;

01/19/2023